Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048943589> ?p ?o ?g. }
- W3048943589 endingPage "105043" @default.
- W3048943589 startingPage "105043" @default.
- W3048943589 abstract "Rett syndrome (RTT; OMIM#312750) is mainly caused by mutations in the X-linked MECP2 gene (methyl-CpG-binding protein 2 gene; OMIM*300005), which leads to impairments in the brain-derived neurotrophic factor (BDNF) signalling. The boost of BDNF mediated effects would be a significant breakthrough but it has been hampered by the difficulty to administer BDNF to the central nervous system. Adenosine, an endogenous neuromodulator, may accomplish that role since through A2AR it potentiates BDNF synaptic actions in healthy animals. We thus characterized several hallmarks of the adenosinergic and BDNF signalling in RTT and explored whether A2AR activation could boost BDNF actions. For this study, the RTT animal model, the Mecp2 knockout (Mecp2−/y) (B6.129P2 (C)-Mecp2tm1.1Bird/J) mouse was used. Whenever possible, parallel data was also obtained from post-mortem brain samples from one RTT patient. Ex vivo extracellular recordings of field excitatory post-synaptic potentials in CA1 hippocampal area were performed to evaluate synaptic transmission and long-term potentiation (LTP). RT-PCR was used to assess mRNA levels and Western Blot or radioligand binding assays were performed to evaluate protein levels. Changes in cortical and hippocampal adenosine content were assessed by liquid chromatography with diode array detection (LC/DAD). Hippocampal ex vivo experiments revealed that the facilitatory actions of BDNF upon LTP is absent in Mecp2−/y mice and that TrkB full-length (TrkB-FL) receptor levels are significantly decreased. Extracts of the hippocampus and cortex of Mecp2−/y mice revealed less adenosine amount as well as less A2AR protein levels when compared to WT littermates, which may partially explain the deficits in adenosinergic tonus in these animals. Remarkably, the lack of BDNF effect on hippocampal LTP in Mecp2−/y mice was overcome by selective activation of A2AR with CGS21680. Overall, in Mecp2−/y mice there is an impairment on adenosinergic system and BDNF signalling. These findings set the stage for adenosine-based pharmacological therapeutic strategies for RTT, highlighting A2AR as a therapeutic target in this devastating pathology." @default.
- W3048943589 created "2020-08-18" @default.
- W3048943589 creator A5000881478 @default.
- W3048943589 creator A5001688753 @default.
- W3048943589 creator A5002865588 @default.
- W3048943589 creator A5021255614 @default.
- W3048943589 creator A5047090081 @default.
- W3048943589 creator A5050081444 @default.
- W3048943589 creator A5051045968 @default.
- W3048943589 creator A5051850476 @default.
- W3048943589 creator A5071704021 @default.
- W3048943589 creator A5076257059 @default.
- W3048943589 creator A5076521538 @default.
- W3048943589 creator A5077551140 @default.
- W3048943589 creator A5080219471 @default.
- W3048943589 creator A5090325742 @default.
- W3048943589 creator A5091606743 @default.
- W3048943589 creator A5030941948 @default.
- W3048943589 date "2020-11-01" @default.
- W3048943589 modified "2023-10-16" @default.
- W3048943589 title "Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling" @default.
- W3048943589 cites W1555679702 @default.
- W3048943589 cites W1559742681 @default.
- W3048943589 cites W1966153941 @default.
- W3048943589 cites W1967133714 @default.
- W3048943589 cites W1967545563 @default.
- W3048943589 cites W1967886362 @default.
- W3048943589 cites W1970151100 @default.
- W3048943589 cites W1971263143 @default.
- W3048943589 cites W1974476511 @default.
- W3048943589 cites W1974814280 @default.
- W3048943589 cites W1975791071 @default.
- W3048943589 cites W1982903836 @default.
- W3048943589 cites W1987829135 @default.
- W3048943589 cites W1991733772 @default.
- W3048943589 cites W1998619221 @default.
- W3048943589 cites W1999775510 @default.
- W3048943589 cites W2000161913 @default.
- W3048943589 cites W2001657520 @default.
- W3048943589 cites W2003448608 @default.
- W3048943589 cites W2007727057 @default.
- W3048943589 cites W2015748323 @default.
- W3048943589 cites W2019388498 @default.
- W3048943589 cites W2021497853 @default.
- W3048943589 cites W2023607520 @default.
- W3048943589 cites W2023731942 @default.
- W3048943589 cites W2030552849 @default.
- W3048943589 cites W2031964878 @default.
- W3048943589 cites W2035090622 @default.
- W3048943589 cites W2036203077 @default.
- W3048943589 cites W2037721754 @default.
- W3048943589 cites W2039276157 @default.
- W3048943589 cites W2041934875 @default.
- W3048943589 cites W2043386629 @default.
- W3048943589 cites W2050252994 @default.
- W3048943589 cites W2054628503 @default.
- W3048943589 cites W2059898784 @default.
- W3048943589 cites W2061311218 @default.
- W3048943589 cites W2061473590 @default.
- W3048943589 cites W2065098417 @default.
- W3048943589 cites W2069312841 @default.
- W3048943589 cites W2069466371 @default.
- W3048943589 cites W2077116340 @default.
- W3048943589 cites W2077720722 @default.
- W3048943589 cites W2081196843 @default.
- W3048943589 cites W2095551600 @default.
- W3048943589 cites W2099530938 @default.
- W3048943589 cites W2104811636 @default.
- W3048943589 cites W2109008714 @default.
- W3048943589 cites W2110412926 @default.
- W3048943589 cites W2114570899 @default.
- W3048943589 cites W2118513080 @default.
- W3048943589 cites W2120112992 @default.
- W3048943589 cites W2127311839 @default.
- W3048943589 cites W2132707897 @default.
- W3048943589 cites W2139064018 @default.
- W3048943589 cites W2144999370 @default.
- W3048943589 cites W2145758516 @default.
- W3048943589 cites W2146632088 @default.
- W3048943589 cites W2152668149 @default.
- W3048943589 cites W2154087863 @default.
- W3048943589 cites W2154727263 @default.
- W3048943589 cites W2157001082 @default.
- W3048943589 cites W2162467606 @default.
- W3048943589 cites W2168886236 @default.
- W3048943589 cites W2513692449 @default.
- W3048943589 cites W2559030088 @default.
- W3048943589 cites W2601748428 @default.
- W3048943589 cites W2609217804 @default.
- W3048943589 cites W2767674328 @default.
- W3048943589 cites W3016463102 @default.
- W3048943589 doi "https://doi.org/10.1016/j.nbd.2020.105043" @default.
- W3048943589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32798727" @default.
- W3048943589 hasPublicationYear "2020" @default.
- W3048943589 type Work @default.
- W3048943589 sameAs 3048943589 @default.
- W3048943589 citedByCount "5" @default.
- W3048943589 countsByYear W30489435892020 @default.